Description
**Product Name:**
– ZYPREXA IM® 10 mg powder for injection
**Qualitative and Quantitative Composition:**
– **Active Ingredient:** Olanzapine 10 mg
– **Excipients:** Lactose monohydrate, tartaric acid. Hydrochloric acid and/or sodium hydroxide may have been used during manufacturing to adjust pH.
**Pharmaceutical Form:**
– ZYPREXA IM is a yellow lyophilized powder in a clear glass vial, intended for intramuscular use only.
**Clinical Particulars:**
**Therapeutic Indications:**
– ZYPREXA IM is indicated for the rapid control of agitation and disturbed behaviors in patients with schizophrenia and related psychoses.
– It is also indicated for patients with acute mania associated with Bipolar I Disorder when oral therapy is not appropriate.
**Dose and Method of Administration:**
– ZYPREXA IM is for intramuscular use only.
– Do not administer intravenously or subcutaneously.
– It is intended for short-term use only.
